The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis

Conclusions:
KRAS mutation was not associated with TTR or OS in patients with metastatic CRC who underwent curative surgery with perioperative chemotherapy.

Source: Epidemiologic Perspectives and Innovations - February 18, 2016 Category: Epidemiology Authors: Hae Su KimJin Seok HeoJeeyun LeeJi Yun LeeMin-Young LeeSung Hee LimWoo Yong LeeSeok Hyung KimYoon Ah ParkYong Beom ChoSeong Hyeon YunSeung Tae KimJoon Oh ParkHo Yeong LimYong Soo ChoiWoo Il KwonHee Cheol KimYoung Suk Park Source Type: research